Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 9895176, 13 pages
http://dx.doi.org/10.1155/2016/9895176
Research Article

Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice

1Postgraduate Program in Experimental Biology, DCBS, Universidad Autónoma Metropolitana Iztapalapa, 09340 Mexico City, DF, Mexico
2Health Science Department, Universidad Autónoma Metropolitana Iztapalapa, 09340 Mexico City, DF, Mexico
3Translational Research Unit, Medica Sur Clinic and Foundation, 14050 Mexico City, DF, Mexico
4Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas de Barcelona, CSIC, Barcelona and Liver Unit-Hospital Clinic-IDIBAPS and Centro de Investigación Biomédica en Red (CIBERehd), 08036 Barcelona, Spain
5Laboratory of Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Centro de Investigación Biomédica en Red (CIBERehd), Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain
6Red “Fisiopatología de Enfermedades Hepáticas” PRODEP-SEP, 09340 Mexico City, DF, Mexico
7General Surgery Service 304, General Hospital of Mexico, UNAM School of Medicine, 06726 Mexico City, DF, Mexico
8Research Center for Alcohol Liver and Pancreatic Diseases and Cirrhosis, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Received 2 May 2016; Accepted 13 July 2016

Academic Editor: Ravirajsinh Jadeja

Copyright © 2016 Natalia Nuño-Lámbarri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Finucane, G. A. Stevens, M. J. Cowan et al., “National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants,” The Lancet, vol. 377, no. 9765, pp. 557–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Lomonaco, N. E. Sunny, F. Bril, and K. Cusi, “Nonalcoholic fatty liver disease: current issues and novel treatment approaches,” Drugs, vol. 73, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Tomita, T. Teratani, T. Suzuki et al., “Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice,” Hepatology, vol. 59, no. 1, pp. 154–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Marí, F. Caballero, A. Colell et al., “Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis,” Cell Metabolism, vol. 4, no. 3, pp. 185–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-J. Lin, C.-K. Lai, M.-C. Kao et al., “Impact of cholesterol on disease progression,” BioMedicine (Netherlands), vol. 5, no. 2, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Arguello, E. Balboa, M. Arrese, and S. Zanlungo, “Recent insights on the role of cholesterol in non-alcoholic fatty liver disease,” Biochimica et Biophysica Acta, vol. 1852, no. 9, pp. 1765–1778, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Ribas, C. García-Ruiz, and J. C. Fernández-Checa, “Glutathione and mitochondria,” Frontiers in Pharmacology, vol. 5, article 151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Caballero, A. Fernández, A. M. De Lacy, J. C. Fernández-Checa, J. Caballería, and C. García-Ruiz, “Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH,” Journal of Hepatology, vol. 50, no. 4, pp. 789–796, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Gutierrez Ruiz, M. Dominguez Perez, S. Rodriguez Gonzalez, N. Nuno Lambarri, C. Licona Retama, and L. E. Gomez-Quiroz, “High cholesterol diet modifies the repairing effect of the hepatocyte growth factor,” Gaceta Medica de Mexico, vol. 148, pp. 236–242, 2012. View at Google Scholar
  10. G. Musso, R. Gambino, and M. Cassader, “Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis,” Progress in Lipid Research, vol. 52, no. 1, pp. 175–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Musso, R. Gambino, F. De Michieli et al., “Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis,” Hepatology, vol. 37, no. 4, pp. 909–916, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Chen, J. Kong, and S. Wu, “Cholesterol gallstone disease: focusing on the role of gallbladder,” Laboratory Investigation, vol. 95, no. 2, pp. 124–131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Allen, H. Jaeschke, and B. L. Copple, “Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis,” American Journal of Pathology, vol. 178, no. 1, pp. 175–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Roma and E. J. Sanchez Pozzi, “Oxidative stress: a radical way to stop making bile,” Annals of Hepatology, vol. 7, no. 1, pp. 16–33, 2008. View at Google Scholar · View at Scopus
  15. B. C. Ferslew, G. Xie, C. K. Johnston et al., “Altered bile acid metabolome in patients with nonalcoholic steatohepatitis,” Digestive Diseases and Sciences, vol. 60, no. 11, pp. 3318–3328, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Domínguez-Pérez, N. Nuño-Lámbarri, D. Clavijo-Cornejo et al., “Hepatocyte growth factor reduces free cholesterol-mediated lipotoxicity in primary hepatocytes by countering oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7960386, 8 pages, 2016. View at Publisher · View at Google Scholar
  17. D. Clavijo-Cornejo, M. Gutiérrez-Carrera, M. Palestino-Domínguez et al., “Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery,” Food and Chemical Toxicology, vol. 69, pp. 102–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Enriquez-Cortina, M. Almonte-Becerril, D. Clavijo-Cornejo et al., “Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage,” Toxicological Sciences, vol. 135, no. 1, pp. 26–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Geerts, E. Vanheule, M. Praet, H. Van Vlierberghe, M. De Vos, and I. Colle, “Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation,” International Journal of Experimental Pathology, vol. 89, no. 4, pp. 251–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kountouras, B. H. Billing, and P. J. Scheuer, “Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat,” British Journal of Experimental Pathology, vol. 65, no. 3, pp. 305–311, 1984. View at Google Scholar · View at Scopus
  21. R. Reinehr, S. Becker, V. Keitel, A. Eberle, S. Grether-Beck, and D. Häussinger, “Bile salt-induced apoptosis involves NADPH oxidase isoform activation,” Gastroenterology, vol. 129, no. 6, pp. 2009–2031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. R. Webster, A. N. Johnston, and M. S. Anwer, “Protein kinase Cδ protects against bile acid apoptosis by suppressing proapoptotic JNK and BIM pathways in human and rat hepatocytes,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 307, no. 12, pp. G1207–G1215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Valdés-Arzate, A. Luna, L. Bucio et al., “Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism,” Free Radical Biology & Medicine, vol. 47, no. 4, pp. 424–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. F. Hofmann, “Cholestatic liver disease: pathophysiology and therapeutic options,” Liver, vol. 22, supplement 2, pp. 14–19, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. B. L. Copple, H. Jaeschke, and C. D. Klaassen, “Oxidative stress and the pathogenesis of cholestasis,” Seminars in Liver Disease, vol. 30, no. 2, pp. 195–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Yasutake, M. Kohjima, K. Kotoh, M. Nakashima, M. Nakamuta, and M. Enjoji, “Dietary habits and behaviors associated with nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1756–1767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Puri, R. A. Baillie, M. M. Wiest et al., “A lipidomic analysis of nonalcoholic fatty liver disease,” Hepatology, vol. 46, no. 4, pp. 1081–1090, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. E. R. Kallwitz, M. L. Daviglus, M. A. Allison et al., “Prevalence of suspected nonalcoholic fatty liver disease in hispanic/latino individuals differs by heritage,” Clinical Gastroenterology and Hepatology, vol. 13, no. 3, pp. 569–576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. B. L. Woolbright, K. Dorko, D. J. Antoine et al., “Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis,” Toxicology and Applied Pharmacology, vol. 283, no. 3, pp. 168–177, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Chatterjee, I. T. G. W. Bijsmans, S. W. C. van Mil, P. Augustijns, and P. Annaert, “Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates,” Toxicology in Vitro, vol. 28, no. 2, pp. 218–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Cheng, Y. Inaba, P. Lu et al., “Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity,” Molecular Endocrinology, vol. 29, no. 4, pp. 571–582, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Bashiri, G. Tavallaee, L. Li, and D. S. Ng, “Emerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease,” Current Opinion in Lipidology, vol. 24, no. 3, pp. 275–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Cole-Ezea, D. Swan, D. Shanley, and J. Hesketh, “Glutathione peroxidase 4 has a major role in protecting mitochondria from oxidative damage and maintaining oxidative phosphorylation complexes in gut epithelial cells,” Free Radical Biology & Medicine, vol. 53, no. 3, pp. 488–497, 2012. View at Publisher · View at Google Scholar · View at Scopus